PMC:7243768 / 59803-60122 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2289","span":{"begin":78,"end":83},"obj":"Gene"},{"id":"2297","span":{"begin":55,"end":64},"obj":"Chemical"},{"id":"2298","span":{"begin":98,"end":107},"obj":"Chemical"},{"id":"2299","span":{"begin":204,"end":213},"obj":"Chemical"},{"id":"2300","span":{"begin":218,"end":227},"obj":"Chemical"}],"attributes":[{"id":"A2289","pred":"tao:has_database_id","subj":"2289","obj":"Gene:1576"},{"id":"A2297","pred":"tao:has_database_id","subj":"2297","obj":"MESH:D019438"},{"id":"A2298","pred":"tao:has_database_id","subj":"2298","obj":"MESH:D061466"},{"id":"A2299","pred":"tao:has_database_id","subj":"2299","obj":"MESH:D061466"},{"id":"A2300","pred":"tao:has_database_id","subj":"2300","obj":"MESH:D019438"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"this combination is usually used in HIV treatment. The ritonavir inhibits the CYP3A metabolism of lopinavir, thereby making the drug available for a longer time by increasing the serum concentration. The lopinavir and ritonavir exhibited very few adverse effects, and beneficial outcomes of this combination of drugs in"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T506","span":{"begin":36,"end":39},"obj":"Body_part"},{"id":"T507","span":{"begin":179,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A506","pred":"fma_id","subj":"T506","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A507","pred":"fma_id","subj":"T507","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"this combination is usually used in HIV treatment. The ritonavir inhibits the CYP3A metabolism of lopinavir, thereby making the drug available for a longer time by increasing the serum concentration. The lopinavir and ritonavir exhibited very few adverse effects, and beneficial outcomes of this combination of drugs in"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T255","span":{"begin":179,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A255","pred":"uberon_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"this combination is usually used in HIV treatment. The ritonavir inhibits the CYP3A metabolism of lopinavir, thereby making the drug available for a longer time by increasing the serum concentration. The lopinavir and ritonavir exhibited very few adverse effects, and beneficial outcomes of this combination of drugs in"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T768","span":{"begin":147,"end":148},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"this combination is usually used in HIV treatment. The ritonavir inhibits the CYP3A metabolism of lopinavir, thereby making the drug available for a longer time by increasing the serum concentration. The lopinavir and ritonavir exhibited very few adverse effects, and beneficial outcomes of this combination of drugs in"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T42","span":{"begin":55,"end":64},"obj":"Chemical"},{"id":"T2445","span":{"begin":98,"end":107},"obj":"Chemical"},{"id":"T61138","span":{"begin":128,"end":132},"obj":"Chemical"},{"id":"T66533","span":{"begin":204,"end":227},"obj":"Chemical"},{"id":"T83936","span":{"begin":204,"end":213},"obj":"Chemical"},{"id":"T18957","span":{"begin":218,"end":227},"obj":"Chemical"},{"id":"T84111","span":{"begin":311,"end":316},"obj":"Chemical"}],"attributes":[{"id":"A1779","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A31514","pred":"chebi_id","subj":"T2445","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A55977","pred":"chebi_id","subj":"T61138","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A3561","pred":"chebi_id","subj":"T66533","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A64853","pred":"chebi_id","subj":"T83936","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A63829","pred":"chebi_id","subj":"T18957","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A89833","pred":"chebi_id","subj":"T84111","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"this combination is usually used in HIV treatment. The ritonavir inhibits the CYP3A metabolism of lopinavir, thereby making the drug available for a longer time by increasing the serum concentration. The lopinavir and ritonavir exhibited very few adverse effects, and beneficial outcomes of this combination of drugs in"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T112","span":{"begin":84,"end":94},"obj":"http://purl.obolibrary.org/obo/GO_0008152"}],"text":"this combination is usually used in HIV treatment. The ritonavir inhibits the CYP3A metabolism of lopinavir, thereby making the drug available for a longer time by increasing the serum concentration. The lopinavir and ritonavir exhibited very few adverse effects, and beneficial outcomes of this combination of drugs in"}

{"project":"LitCovid-sentences","denotations":[{"id":"T432","span":{"begin":51,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"this combination is usually used in HIV treatment. The ritonavir inhibits the CYP3A metabolism of lopinavir, thereby making the drug available for a longer time by increasing the serum concentration. The lopinavir and ritonavir exhibited very few adverse effects, and beneficial outcomes of this combination of drugs in"}